SG11201404277WA - Aurora and flt3 kinases modulators - Google Patents
Aurora and flt3 kinases modulatorsInfo
- Publication number
- SG11201404277WA SG11201404277WA SG11201404277WA SG11201404277WA SG11201404277WA SG 11201404277W A SG11201404277W A SG 11201404277WA SG 11201404277W A SG11201404277W A SG 11201404277WA SG 11201404277W A SG11201404277W A SG 11201404277WA SG 11201404277W A SG11201404277W A SG 11201404277WA
- Authority
- SG
- Singapore
- Prior art keywords
- aurora
- flt3 kinases
- modulators
- kinases modulators
- flt3
- Prior art date
Links
- 101100335081 Mus musculus Flt3 gene Proteins 0.000 title 1
- 239000005441 aurora Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1202027.7A GB201202027D0 (en) | 2012-02-06 | 2012-02-06 | Pharmaceutical compounds |
| PCT/EP2013/052182 WO2013117522A1 (en) | 2012-02-06 | 2013-02-04 | Aurora and flt3 kinases modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201404277WA true SG11201404277WA (en) | 2014-08-28 |
Family
ID=45896692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201404277WA SG11201404277WA (en) | 2012-02-06 | 2013-02-04 | Aurora and flt3 kinases modulators |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9133180B2 (en) |
| EP (1) | EP2812328B1 (en) |
| JP (1) | JP6034880B2 (en) |
| KR (1) | KR102052780B1 (en) |
| CN (1) | CN104169277B (en) |
| AU (1) | AU2013218167B2 (en) |
| BR (1) | BR112014019254B1 (en) |
| CA (1) | CA2863759C (en) |
| DK (1) | DK2812328T3 (en) |
| ES (1) | ES2560260T3 (en) |
| GB (1) | GB201202027D0 (en) |
| IL (1) | IL233988A (en) |
| MX (1) | MX338481B (en) |
| PL (1) | PL2812328T3 (en) |
| PT (1) | PT2812328E (en) |
| RU (1) | RU2643809C2 (en) |
| SG (1) | SG11201404277WA (en) |
| WO (1) | WO2013117522A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2522968B2 (en) | 1987-10-23 | 1996-08-07 | 尾池工業株式会社 | Printed circuit transfer foil and manufacturing method thereof |
| JP7365332B2 (en) * | 2017-08-07 | 2023-10-19 | ジョイント・ストック・カンパニー “バイオキャド” | Novel heterocyclic compounds as CDK8/19 inhibitors |
| GB201816369D0 (en) | 2018-10-08 | 2018-11-28 | Sareum Ltd | Pharmaceutical compounds |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE794096A (en) | 1972-08-07 | 1973-05-16 | Lepetit Spa | 2,4,5-TRISUBSTITU OXAZOLES AND THEIR PREPARATION |
| US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
| US5272057A (en) | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
| US5192659A (en) | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
| JPH06310767A (en) | 1993-04-26 | 1994-11-04 | Nec Corp | Thermal insulation supporting structure for cryogen container |
| EP0951541B1 (en) | 1995-07-31 | 2005-11-30 | Urocor, Inc. | Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
| US6218529B1 (en) | 1995-07-31 | 2001-04-17 | Urocor, Inc. | Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer |
| DE19653355A1 (en) | 1996-12-20 | 1998-06-25 | Dresden Arzneimittel | New amino-phenyl-imidazole carboxylic acid ester or amide compounds |
| GB0003154D0 (en) | 2000-02-12 | 2000-04-05 | Astrazeneca Uk Ltd | Novel compounds |
| IL153246A0 (en) | 2000-06-28 | 2003-07-06 | Astrazeneca Ab | Substituted quinazoline derivatives and their use as inhibitors |
| DE60128731T2 (en) | 2000-10-30 | 2008-02-07 | Janssen Pharmaceutica N.V. | Tripeptidylpeptidase INHIBITORS |
| US7361665B2 (en) | 2002-07-09 | 2008-04-22 | Vertex Pharmaceuticals Incorporated | Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases |
| AU2003902208A0 (en) * | 2003-05-08 | 2003-05-22 | Fujisawa Pharmaceutical Co., Ltd. | Inhibitor of cox |
| EP1684750B1 (en) | 2003-10-23 | 2010-04-28 | AB Science | 2-aminoaryloxazole compounds as tyrosine kinase inhibitors |
| AU2005243175B2 (en) * | 2004-05-14 | 2011-12-01 | Millennium Pharmaceuticals, Inc. | Compounds and methods for inhibiting mitotic progression by inhibition of Aurora kinase |
| GB0504753D0 (en) | 2005-03-08 | 2005-04-13 | Astrazeneca Ab | Chemical compounds |
| JP5222561B2 (en) | 2005-10-07 | 2013-06-26 | キッセイ薬品工業株式会社 | Nitrogen-containing aromatic heterocyclic compound and pharmaceutical composition containing the same |
| DK200600313A (en) | 2006-03-03 | 2006-03-13 | Novo Nordisk As | Treating type 2 diabetes or metabolic syndrome with an interleukin 1beta inhibitor or an interleukin 1beta synthesis or release inhibitor |
| ES2352320T3 (en) | 2006-05-12 | 2011-02-17 | Ab Science | NEW PROCEDURE FOR THE SYNTHESIS OF 2-AMINOXAZOL COMPOUNDS. |
| WO2008024980A2 (en) * | 2006-08-24 | 2008-02-28 | Serenex, Inc. | Pyrrole, thiophene, furan, imidazole, oxazole, and thiazole derivatives |
| JO2701B1 (en) * | 2006-12-21 | 2013-03-03 | جلاكسو جروب ليميتد | Compounds |
| GB0709031D0 (en) | 2007-05-10 | 2007-06-20 | Sareum Ltd | Pharmaceutical compounds |
| EP2278969B1 (en) | 2008-04-21 | 2013-02-13 | Merck Sharp & Dohme Corp. | Inhibitors of Janus kinases |
| GB0820819D0 (en) * | 2008-11-13 | 2008-12-24 | Sareum Ltd | Pharmaceutical compounds |
| EP2320293A1 (en) * | 2009-11-05 | 2011-05-11 | Koninklijke Philips Electronics N.V. | Sleep element for improving the sleep of a person |
| ES2539170T3 (en) * | 2010-01-12 | 2015-06-26 | Ab Science | Oxazole Kinase Inhibitors |
| WO2012021611A1 (en) | 2010-08-11 | 2012-02-16 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| EP3040336B1 (en) | 2012-03-02 | 2020-04-08 | Sareum Limited | Compounds for use in treating tyk2 kinase mediated conditions |
-
2012
- 2012-02-06 GB GBGB1202027.7A patent/GB201202027D0/en not_active Ceased
-
2013
- 2013-02-04 SG SG11201404277WA patent/SG11201404277WA/en unknown
- 2013-02-04 BR BR112014019254-5A patent/BR112014019254B1/en not_active IP Right Cessation
- 2013-02-04 JP JP2014555250A patent/JP6034880B2/en active Active
- 2013-02-04 AU AU2013218167A patent/AU2013218167B2/en not_active Ceased
- 2013-02-04 CA CA2863759A patent/CA2863759C/en active Active
- 2013-02-04 US US14/376,729 patent/US9133180B2/en active Active
- 2013-02-04 CN CN201380013544.5A patent/CN104169277B/en not_active Expired - Fee Related
- 2013-02-04 ES ES13702642.3T patent/ES2560260T3/en active Active
- 2013-02-04 PT PT137026423T patent/PT2812328E/en unknown
- 2013-02-04 RU RU2014131784A patent/RU2643809C2/en active
- 2013-02-04 EP EP13702642.3A patent/EP2812328B1/en active Active
- 2013-02-04 MX MX2014009323A patent/MX338481B/en active IP Right Grant
- 2013-02-04 WO PCT/EP2013/052182 patent/WO2013117522A1/en not_active Ceased
- 2013-02-04 KR KR1020147024086A patent/KR102052780B1/en active Active
- 2013-02-04 DK DK13702642.3T patent/DK2812328T3/en active
- 2013-02-04 PL PL13702642T patent/PL2812328T3/en unknown
-
2014
- 2014-08-05 IL IL233988A patent/IL233988A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| JP6034880B2 (en) | 2016-11-30 |
| EP2812328B1 (en) | 2015-11-18 |
| HK1204327A1 (en) | 2015-11-13 |
| CN104169277B (en) | 2016-10-12 |
| DK2812328T3 (en) | 2016-01-11 |
| ES2560260T3 (en) | 2016-02-18 |
| CA2863759C (en) | 2020-04-14 |
| CN104169277A (en) | 2014-11-26 |
| GB201202027D0 (en) | 2012-03-21 |
| WO2013117522A1 (en) | 2013-08-15 |
| JP2015511228A (en) | 2015-04-16 |
| KR20140128373A (en) | 2014-11-05 |
| AU2013218167A1 (en) | 2014-08-14 |
| MX2014009323A (en) | 2015-04-08 |
| US20150018367A1 (en) | 2015-01-15 |
| US9133180B2 (en) | 2015-09-15 |
| EP2812328A1 (en) | 2014-12-17 |
| PL2812328T3 (en) | 2016-04-29 |
| AU2013218167B2 (en) | 2017-04-06 |
| MX338481B (en) | 2016-04-19 |
| PT2812328E (en) | 2016-03-01 |
| BR112014019254A2 (en) | 2017-06-20 |
| BR112014019254B1 (en) | 2020-03-10 |
| RU2643809C2 (en) | 2018-02-06 |
| IL233988A (en) | 2017-06-29 |
| BR112014019254A8 (en) | 2017-07-11 |
| KR102052780B1 (en) | 2019-12-05 |
| CA2863759A1 (en) | 2013-08-15 |
| RU2014131784A (en) | 2016-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL235362A0 (en) | Complement pathway modulators and uses thereof | |
| IL245733A0 (en) | Aplnr modulators and uses thereof | |
| SG11201405131XA (en) | Dll3 modulators and methods of use | |
| PL3321268T3 (en) | Bicyclic heteroaryl derivatives as mnk1 and mnk2 modulators and uses thereof | |
| EP2844247A4 (en) | Ror modulators and their uses | |
| PL2712601T3 (en) | Fluidic methods and devices | |
| IL235826A0 (en) | New diazaspirocycloalkane and azaspirocycloalkane | |
| EP2934342A4 (en) | Discectomy devices and methods | |
| AU2013203459A1 (en) | DLL3 modulators and methods of use | |
| EP2863973A4 (en) | Powder dispersion devices and methods | |
| AU350839S (en) | Carafe and stopper therefore | |
| EP2828258A4 (en) | Novelpyridopyrimidine derivatives and use thereof | |
| IL240929A0 (en) | Substituted-7 azabicycles and their use as orexin receptor modulators | |
| EP2806918A4 (en) | Methods and devices for autoflush syringes | |
| IL237926A0 (en) | Combinations and uses thereof | |
| EP2844259A4 (en) | Ror modulators and their uses | |
| EP2844260A4 (en) | Ror modulators and their uses | |
| ZA201405392B (en) | Substituted phenylimidazopyrazoles and use thereof | |
| SG11201504482VA (en) | Beta-hexosyl-transferases and uses thereof | |
| EP2857219A4 (en) | Cap for writing implement and writing implement | |
| SG11201404277WA (en) | Aurora and flt3 kinases modulators | |
| ZA201408128B (en) | Etract of greyia radlkoferi and use thereof | |
| GB201222541D0 (en) | Kiddibidet and pottibidet | |
| IL218974A0 (en) | Conaction bitwen coutch and playels | |
| GB201202021D0 (en) | Co-sleeper and breastfeeder |